Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition

Pancreatic ductal adenocarcinoma (PDAC) features a near-universal mutation in KRAS. Additionally, the tumor suppressor PTEN is lost in ∼10% of patients, and in mouse models, this dramatically accelerates tumor progression. While oncogenic KRAS and phosphatidylinositol 3-kinase (PI3K) cause divergent...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalopoulou, Evdokia, Auciello, Francesca R., Bulusu, Vinay, Strachan, David, Campbell, Andrew D., Tait-Mulder, Jacqueline, Karim, Saadia A., Morton, Jennifer P., Sansom, Owen J., Kamphorst, Jurre J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043007/
https://www.ncbi.nlm.nih.gov/pubmed/32101748
http://dx.doi.org/10.1016/j.celrep.2020.01.080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043007/
https://www.ncbi.nlm.nih.gov/pubmed/32101748
http://dx.doi.org/10.1016/j.celrep.2020.01.080

Ejemplares similares